179 related articles for article (PubMed ID: 17437513)
41. Effects of menopausal hormone therapy on cardiovascular diseases and type 2 diabetes in middle-aged postmenopausal women: analysis of the Korea National Health Insurance Service Database.
Kim JE; Choi J; Park J; Shin A; Choi NK; Choi JY
Menopause; 2021 Sep; 28(11):1225-1232. PubMed ID: 34520413
[TBL] [Abstract][Full Text] [Related]
42. Benign gallbladder disease: newer data suggest little or no excess risk with oral contraceptive use.
Contracept Rep; 1997 Nov; 8(5):9-11. PubMed ID: 12348251
[TBL] [Abstract][Full Text] [Related]
43. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.
Staller K; Townsend MK; Khalili H; Mehta R; Grodstein F; Whitehead WE; Matthews CA; Kuo B; Chan AT
Gastroenterology; 2017 Jun; 152(8):1915-1921.e1. PubMed ID: 28209529
[TBL] [Abstract][Full Text] [Related]
44. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
[TBL] [Abstract][Full Text] [Related]
45. Self-reported data on reproductive variables were reliable among postmenopausal women.
Lucas R; Azevedo A; Barros H
J Clin Epidemiol; 2008 Sep; 61(9):945-50. PubMed ID: 18468857
[TBL] [Abstract][Full Text] [Related]
46. Understanding the menopausal experiences of professional women.
Simon JA; Reape KZ
Menopause; 2009; 16(1):73-6. PubMed ID: 18779760
[TBL] [Abstract][Full Text] [Related]
47. Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.
Khatibi A; Agardh CD; Shakir YA; Nerbrand C; Nyberg P; Lidfeldt J; Samsioe G
Climacteric; 2007 Oct; 10(5):386-92. PubMed ID: 17852141
[TBL] [Abstract][Full Text] [Related]
48. Menopausal symptoms and quality of life during the menopausal transition in Sri Lankan women.
Waidyasekera H; Wijewardena K; Lindmark G; Naessen T
Menopause; 2009; 16(1):164-70. PubMed ID: 18703984
[TBL] [Abstract][Full Text] [Related]
49. Life prevalence of hormone replacement therapy and profile of users have not changed among women with self-reported menopause in the last two decades in Porto, Portugal.
Lucas R; Barros H
Climacteric; 2008 Feb; 11(1):26-31. PubMed ID: 18202962
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and risk factors of urinary incontinence in Khon Kaen menopausal women.
Sakondhavat C; Choosuwan C; Kaewrudee S; Soontrapa S; Louanka K
J Med Assoc Thai; 2007 Dec; 90(12):2553-8. PubMed ID: 18386703
[TBL] [Abstract][Full Text] [Related]
51. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
Col NF; Guthrie JR; Politi M; Dennerstein L
Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
[TBL] [Abstract][Full Text] [Related]
52. Calcium intake is inversely associated with metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Survey, 2001 and 2005.
Cho GJ; Park HT; Shin JH; Hur JY; Kim YT; Kim SH; Lee KW; Kim T
Menopause; 2009; 16(5):992-7. PubMed ID: 19741428
[TBL] [Abstract][Full Text] [Related]
53. Effect of menopausal hormone therapy on the levels of magnesium, zinc, lead and cadmium in post-menopausal women.
Jurczak A; Brodowski J; Grochans E; Karakiewicz B; Szkup-Jabłońska M; Wieder-Huszla S; Mroczek B; Włoszczak-Szubzda A; Grzywacz A
Ann Agric Environ Med; 2013; 20(1):147-51. PubMed ID: 23540229
[TBL] [Abstract][Full Text] [Related]
54. Menopausal hormone therapy use and breast cancer risk in Australia: Findings from the New South Wales Cancer, Lifestyle and Evaluation of Risk study.
Salagame U; Banks E; Sitas F; Canfell K
Int J Cancer; 2016 Apr; 138(8):1905-14. PubMed ID: 26599391
[TBL] [Abstract][Full Text] [Related]
55. Hormone therapy and Hypertension in Postmenopausal Women: Results from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
Ferreira-Campos L; Gabrielli L; Almeida MDCC; Aquino EML; Matos SMA; Griep RH; Aras R
Arq Bras Cardiol; 2022 May; 118(5):905-913. PubMed ID: 35613189
[TBL] [Abstract][Full Text] [Related]
56. Segmental adenomyomatosis of the gallbladder predisposes to cholecystolithiasis.
Nishimura A; Shirai Y; Hatakeyama K
J Hepatobiliary Pancreat Surg; 2004; 11(5):342-7. PubMed ID: 15549435
[TBL] [Abstract][Full Text] [Related]
57. The influence of menopausal hormone therapy on tumour characteristics and survival in endometrial cancer patients.
Orgéas CC; Hall P; Wedrén S; Dickman PW; Czene K
Eur J Cancer; 2009 Nov; 45(17):3064-73. PubMed ID: 19493676
[TBL] [Abstract][Full Text] [Related]
58. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
[TBL] [Abstract][Full Text] [Related]
59. Knee osteoarthritis and menopausal hormone therapy in postmenopausal women: a nationwide cross-sectional study.
Jung JH; Bang CH; Song GG; Kim C; Kim JH; Choi SJ
Menopause; 2018 Dec; 26(6):598-602. PubMed ID: 30586007
[TBL] [Abstract][Full Text] [Related]
60. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
Manson JE; Bassuk SS
Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
